Table 3.
GLS and myocardial work parameters between two groups and study phase.
| Intensive treatment (N = 66) | Standard treatment (N = 50) | p Value | ||||
|---|---|---|---|---|---|---|
| Phase 1 | Phase 2 | Phase 1 | Phase 2 | Treatment | Phase | |
| GLS (%) | −17.4 ± 2.1 | −16.0 ± 2.8 | −17.6 ± 2.4 | −16.4 ± 2.6 | .518 | <.001 |
| GWI (mmHg%) | 1721.4 ± 192.8 | 1546.0 ± 286.1 | 1788.0 ± 264.4 | 1720.6 ± 269.7 | .052*, ‡ | |
| GCW (mmHg%) | 2071.4 ± 231.5 | 1922.4 ± 265.9 | 2156.5 ± 279.8 | 2125.3 ± 274.2 | .045*, ‡ | |
| GWW (mmHg%) | 158.7 ± 110.2 | 192.4 ± 108.3 | 140.0 ± 78.1 | 186.1 ± 124.0 | .445 | .001 |
| GWE (%) | 91.9 ± 4.2 | 89.6 ± 5.5 | 92.8 ± 3.3 | 91.2 ± 4.7 | .087 | <.001 |
Note: If no interaction between phase and treatment group exists, then data were analyzed together, with the p values as shown in the final two columns. If a phase × treatment interaction exists (i.e., effects differ over time between the two groups), this p value is shown across both final columns, then data were analyzed separately by phase and treatment. p < .05 intensive versus standard phase 1. p < .05 phase 1 versus phase 2 standard.
Abbreviation: GCW, global constructive work; GLS, global longitudinal strain; GWE, global work efficiency; GWI, global work index; GWW, global wasted work.
p < .05 phase 1 versus phase 2 intensive.
p < .05 intensive versus standard phase 2.